Navigation Links
ISPE Launches New Expanded E-Learning Courses
Date:11/1/2013

Tampa, FL (PRWEB) November 01, 2013

ISPE has announced the launch of new E-Learning courses, designed to offer pharmaceutical manufacturing professionals the opportunity to take ISPE’s signature training through a convenient web-based platform. ISPE E-Learning now offers expanded, interactive courses on Auditing for the Pharmaceutical Industry, Basic Principles of Computerized Systems Compliance (GAMP® 5), Biotechnology and Containment Fundamentals, with additional courses in development to launch in 2014.

“ISPE is dedicated to providing its Members and the pharmaceutical industry with best-in-class education opportunities and is continually exploring new ways to enhance our education offerings to meet the needs of a variety of audiences,” said ISPE President and CEO Nancy Berg. “The new E-Learning courses round out ISPE’s industry-leading stable of training programs, enabling attendees to take advantage of training at times and locations that are convenient to them, across time zones and geographic locations.”

The new ISPE E-Learning courses have been designed as interactive experiences, with pre-class assessments to identify knowledge gaps, links to regulatory information and final assessments to measure comprehension. Narrated slides, graphs and checklists demonstrate practical, science-based solutions that have been devised by ISPE instructors, who are industry experts in their field of instruction. Continuing Education Units (CEUs) are available to those who complete training courses, including those available through E-Learning.

More information about ISPE’s new E-Learning courses, including complimentary demonstrations and a free module from the Auditing course, is available at http://www.ISPE.org/ELearning. Information on I
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Tute Genomics Launches at 2013 ASHG Conference
2. Trade Show Display Co. GLM Displays Launches New “Customer Spotlight” Campaign
3. How Companies Can Provide Extraordinary New B2B Products with Extraordinary Product Launches - A Sales Momentum White Paper
4. QB3 Launches New Biotech Incubator in San Francisco with 24 Companies
5. Singapore Focus Chemistry Launches New Website, Www.FocusChemistry.Com, Targeting A Level Chemistry Students
6. SoundConnect Launches Innovative Channel Partner Webinar Series
7. DiaCarta Inc. Launches QClamp™ Somatic Mutation Real-Time PCR Tests for KRAS, NRAS, EGFR, BRAF, PIK3CA and More Without DNA Extractions
8. KEW Group Launches CancerPlex(SM) Assay to Bring State-of-the-Art Genomic Testing to Community Oncologists
9. Cyndy Nayer Launches Center of Health Engagement
10. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
11. Pipette.com Launches New Blog Solutions.Pipette.com to Help Scientists Find Liquid Handling Answers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , September 2, 2015 Biovista ... winners of the 2015 BeHEARD science challenge, a global ... rare disease researchers, access to the latest life science ... drug repositioning and pathway analytics capability to support ... Foundation in the study of Niemann-Pick Disease Type A ...
(Date:9/2/2015)... Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., announced ... the multicenter Phase 2 clinical trial of NT-503 ... of recurrent subfoveal choroidal neovascularization secondary to age ... unique vascular endothelial growth factor (VEGF) receptor protein ... "This landmark proof-of-concept study will evaluate NT-503 ...
(Date:9/2/2015)... 2015 Aytu BioScience, Inc. (OTCQB: AYTU), a ... and related conditions, announced today that it has closed ... note financing, raising a total of $5.175 million, which ... Josh Disbrow , Chief Executive ... are intended to be used to conduct clinical studies ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... , SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: OMER ... September 30, 2009. For the three months ended September 30, 2009, ... share, as compared to a net loss of $7.4 million, or ... nine months ended September 30, 2009, the Company reported a net ...
... Nov. 19 NeoStem, Inc. (NYSE Amex: NBS ... letter to its shareholders, discussing the Company,s acquisition, on ... an integrated bio-pharmaceutical company based in the People,s Republic ... interest in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s primary ...
... , , ... GmbH,announced that they have filed on November 16th, 2009 ... orphan drug status designation with the European Medicines Agency,(EMEA). ... advanced Parkinson,s and a serious burden to some of ...
Cached Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. ... human interface solutions, today announced that four of ... Match-in-Sensor solution, have officially been named FIDO Certified™ ... part of the certification, Synaptics, Natural ID™ fingerprint ... Universal Authentication Framework (UAF) standard and are interoperable ...
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
(Date:8/5/2015)... ALBANY, New York , August 5, 2015 /PRNewswire/ ... new market report titled "Facial Recognition Market - Global ... - 2022", the global market for facial recognition is ... market is driven by increased demand for surveillance systems ... to the rising number of crimes and terrorist activities ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... the seas include overfishing, overfertilisation with nutrients and the ... there are the effects of climate change. However, we ... parameters such as currents, water temperature or algae concentration", ... Coastal Research of the GKSS Geesthacht Research Centre. ...
... work originally designed to remove contaminants from soil, ... Brookhaven National Laboratory and their Belgium colleagues at ... improve plant growth on marginal land. The findings, ... Applied and Environmental Microbiology , may help ...
... Singapore (GIS) and the Anhui Medical University, China, have identified ... psoriasis, a common chronic skin disease. The research, led ... Jianjun, will be published online on 25 Jan. 2009 in ... in the human genomes of a large cohort of patients ...
Cached Biology News:GKSS to invest 12 million euros ($15.48 million) in a new observation system for the North Sea 2Scientists identify bacteria that increase plant growth 2Scientists identify bacteria that increase plant growth 3Compromised skin barrier function plays a role in psorasis development 2
... is a recombinant Moloney murine leukemia ... Transcriptase is similar to MuLV reverse ... usage. MuLV reverse transcriptase is a ... single-stranded RNA as a template in ...
... Application: Useful for the determination of digitonin ... sucrose, 0.4% EDTA Na 4 and 0.06% ... Nakao, et al., Biochem. Biophys. Res. Commun., ... liberate 1.0 mole of inorganic phosphorus from ATP ...
... Recombinant type 14 3C protease from ... addition to the Novagen brand line of ... a highly purified recombinant 6XHis-fusion protein, which ... native enzyme: LeuGluValLeuPheGln/GlyPro. The small, 22 KDa ...
... The IEC Centra CL3 series ... in typical research and clinical applications ... broad accessory package includes quick connect ... An advanced yet intuitive interface allows ...
Biology Products: